Aksys Ltd. to Present at Piper Jaffray Healthcare Conference.
PIPER JAFFRAY HEALTHCARE CONFERENCE, NEW YORK, Feb. 4 /PRNewswire/
-- Aksys, Ltd., founded in January 1991, is developing a breakthrough
personalized hemodialysis (PHD(TM)) system which will greatly improve
the health, quality of life, and disease management of patients with End
Stage Renal Disease (ESRD). By using proprietary technology to overcome
limitations of current dialysis methods, Aksys has created a completely
automated and exceptionally user friendly dialysis system for frequent
use at home or at a limited care facility. With the Aksys PHD(TM)
system, patients with ESRD will have, for the first time, use of a
simple and reliable personalized hemodialysis system which offers
significant economic and clinical advantages over in-center hemodialysis
and home peritoneal dialysis (PD). Aksys completed its IPO in May of
1996, raising $53 million. This will enable the Company to complete
product development, clinical evaluation, regulatory filings and launch
the product in the second half of 1999 in the U.S. and/or Europe.